George Frangeskides, Exec-Chair at Alba Mineral Resources, discusses grades at the Clogau Gold Mine. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIPEL.L Regulatory News (IPEL)

  • There is currently no data for IPEL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

30 Jul 2019 07:00

RNS Number : 1126H
Impellam Group plc
30 July 2019
 

 

 

INTERIM RESULTS - UNAUDITED 

Impellam Group plc ("Impellam") - London AIM: IPEL; 30 July 2019Impellam announces its unaudited interim results for the 26 weeks ended 5 July 2019

Revenue and Gross Profit Resilience Continues

 

 

 

H1 20191

H1 20181,2

Actual Inc/(Dec)

Like-for-like(8) Inc/(Dec)

Revenue (£ millions)

 

£1,135.0

£1,107.7

2.5%

1.4%

 

 

 

 

 

 

Gross Profit (£ millions)

 

£135.5

£133.3

1.7%

0.1%

 

 

 

 

 

 

Adjusted EBITDA (3)

(£ millions)

 

£25.1

£22.1

13.6%

6.0%

 

 

 

 

 

 

Adjusted EBITDA conversion (4)

 

18.5%

16.6%

1.9 ppts

 

 

 

 

 

 

 

Adjusted operating profit (5)

 

£15.9

£17.9

(11.2)%

(20.2)%

 

 

 

 

 

 

Adjusted operating profit conversion (6)

 

11.7%

13.4%

(1.7) ppts

 

 

 

 

 

 

 

Operating profit (£ millions)

 

£9.4

£15.3

(38.6)%

(45.3)%

 

 

 

 

 

 

Continuing Adjusted Basic EPS (7)

 

19.2p

25.3p

(24.1)%

 

 

 

 

 

 

 

Continuing Basic EPS

 

8.5p

20.9p

(59.3)%

 

 

 

 

 

 

 

 

Financial results presentation

In 2019 we have adopted IFRS 15 - Revenue from Contracts with Customers and IFRS16 - Leases. We are required to restate the 2018 comparative results for the IFRS 15 impact (£23.9m increase in revenue, but no impact on gross profit, adjusted EBITDA or operating profit). For IFRS 16 we have applied the modified retrospective approach and have therefore not restated the 2018 comparative results for the new standard's material impact.

IFRS 16 affects adjusted EBITDA, operating profit and net debt and therefore the year-on-year results as reported are not shown on a comparable basis.

The de-merger of Carlisle Support Services in 2019 has been treated as a discontinued operation and the 2018 results have been restated accordingly.

Towards the end of 2018 the Group changed its estimate of the useful economic life over which it carries brand values. This has led to an amortisation charge in H1 2019 of £3.2m (H1 2018 had no such charge).

Following these regulatory changes the Group is adopting 'Adjusted Operating Profit' as its Alternative Performance Measure (APM) for earnings, as this is stated after charging the costs re-characterised under IFRS 16. As with Adjusted EBITDA previously, it continues to exclude the amortisation of acquired intangibles (brand value and customer relationships).

 

 

 

The table below bridges H1 2018 to H1 2019 on a comparable basis at actual exchange rates.

 

 

Reported

Discontinued Ops

IFRS 15

Restated

Comparable

IFRS 16

Brand Value

Reported

 

H1 2018

H1 2018

H1 2018

H1 2018

H1 2019

H1 2019

H1 2019

H1 2019

Revenue

1,109.6

(25.8)

23.9

1,107.7

1,135.0

0.0

0.0

1,135.0

Gross Profit

135.5

(2.2)

0.0

133.3

135.5

0.0

0.0

135.5

Adjusted EBITDA3

22.2

(0.1)

0.0

22.1

20.1

5.0

0.0

25.1

Adjusted Operating Profit5

18.0

(0.1)

0.0

17.9

15.5

0.4

0.0

15.9

Operating Profit

15.4

(0.1)

0.0

15.3

12.2

0.4

(3.2)

9.4

Net Debt

79.1

0.0

0.0

79.1

75.0

24.9

0.0

99.9

 

 

 

(1) IFRS 15 - Revenue from Contracts with Customers was adopted in 2019, 2018 financial statements were restated (see note 4). IFRS 16 - Leases was adopted in 2019, 2018 financial statements are not restated (see note 10).

(2) 2018 financial statements restated for discontinued operations (see note 3).

(3) Before separately disclosed items (see note 5) and share-based payment (see note 2).

(4) Calculated as Adjusted EBITDA / Gross Profit.

(5) Operating profit before amortisation of acquired intangible assets, separately disclosed items (see note 5) and share-based payment (see note 2).

(6) Calculated as Adjusted operating profit / Gross Profit.

(7) Continuing Basic EPS before separately disclosed items (see note 5), share-based payment (see note 2) and amortisation of acquired intangible assets (see note 8).

(8) % change measured at constant exchange rates.

 

 

 

 

 

Key operational highlights

§ The Group has reviewed its segmental management and reporting structure alongside its strategic initiatives. The key segments are now Global Managed Services, Global Specialist Staffing, Regional Specialist Staffing and Healthcare.

§ The new structure supports an increasingly integrated business model which will drive increased collaboration and reduce duplication and costs across the Group.

§ Group revenues increased by 1.4% at constant exchange rates (2.5% increase at actual exchange rates) and gross profit increased marginally by 0.1% at constant exchange rates (1.7% increase at actual exchange rates). The Group has delivered a solid performance across the portfolio although challenging market conditions have negatively impacted the retail, automotive and healthcare sectors.

§ Adjusted EBITDA is up £3m compared to the same period last year. The impact of two previously reported customer losses in the US together with the implementation costs of significant customer wins in the UK and US has led to a £2m decrease in adjusted EBITDA which is offset by a £5.0m improvement due to the adoption of IFRS 16.

§ Operating profit was £9.4m (2018: £15.3m). In addition to the adjusted EBITDA shortfall this was impacted by the change made in December 2018 to the estimated economic useful life used for Brand Value amortisation (£3.2m) and an increase in separately disclosed items from £0.4m to £1.5m.

§ Net debt was reduced by 5.2% from £79.1 million at H1 2018 to £75.0 million at H1 2019 excluding the impact of IFRS 16. The effect of IFRS 16 is the recognition of additional Net Debt (lease liabilities) of £24.9m. With this included, reported net debt increases year-on-year by £20.8m to £99.9m.

§ On the 7th March Carlisle Support Services Group was de-merged from the Group, allowing Impellam to further focus on its portfolio of Managed Services and Specialist Staffing businesses.

§ On the 8th July Impellam acquired Flexy Corporation Limited, a leading flexible staffing platform based in London which will enable the Group to offer new solutions, more choice, and better, technology-led experiences for customers and candidates alike.

 

Julia Robertson, Chief Executive Officer, commented:

"Despite continuing challenging trading conditions in the UK and the final exit of customer losses notified in 2018 I am pleased to report revenue growth of 1.4% (at constant exchange rates) and overall gross profit in line with last year (at constant exchange rates).

Encouraged by this stable revenue and gross profit performance we are focused on transforming the Group and creating a business model which further improves collaboration (Group Supply1 and cross sell) and reduces costs arising from duplication (IT systems, support services, back offices and recruitment process).

Our new segmental structure will allow increased integration of the brands under collaborative management. Global Managed Services includes our core managed service providers Guidant Global and Comensura which operate in the UK, US, Europe and Australasia. Global Specialist Staffing includes the technology brands (Lorien, OneZeero and Scom) and life sciences brands (SRG and SRG Woolf) which operate across the UK, US and Europe. Regional Specialist Staffing includes the brands that are industry specialists in their own territory - Blue Arrow, Tate, Carbon60, Celsian, Career Teachers and Chadwick Nott in the UK and Bartech Staffing and Corestaff in the US. The Healthcare segment is Medacs Global Group which operates in the UK, Europe and Australasia.

The leaders of our three core segments, Global Managed Services, Global Specialist Staffing and Regional Specialist Staffing are working closely together in pursuit of our strategic goals and early signs for future quality of earnings improvements and cost reductions are promising.

The new structure of the business is accelerating collaboration between the brands and continued focus on Group Supply1 is delivering benefits to both the Managed Services and Specialist Staffing businesses. An increased focus on Group Supply1 in the US means that this has grown by 0.5ppts to 8.0% (excluding the loss of 2 clients during 2018). In the UK Group Supply1 has increased by 0.3ppts.

Our Global Managed Services businesses are winning a record number of new customers. Notwithstanding success in acquiring new customers, Guidant Global gross profit is down 6.9% (at constant exchange rates) due to the impact of previously reported lost customers and additional costs in implementation of new customers. Comensura delivered a strong H1 performance in the UK, and Australasia gross profit grew by 24.1%. Younifi, our new innovative platform solution in the social care market, has passed an important milestone and is in the midst of implementing its first customer.

Our Global Specialist Staffing businesses have seen growth in the Life Sciences market (SRG and SRG Woolf), particularly in the UK. Although the Technology businesses (Lorien, OneZeero and Scom) have delivered in line with prior year we are seeing a slowdown in the UK, offset with strong performance in the US. Whilst contract hiring remains stable there are early signs of an increase in permanent hiring, possibly driven by concerns around IR35 or the impact of Brexit.

In our Regional Specialist businesses we continue to experience challenges in the UK as a result of difficult market conditions, particularly in the retail and automotive sectors, as well as the ongoing uncertainty of Brexit. However we are seeing gross profit growth in Education and Legal in the UK and Engineering in both the UK and US and we continue to drive Group Supply1, particularly in the US businesses. With an increased focus on eradicating duplication and scrupulous cost management we have identified a number of savings for H2 to improve gross profit conversion to offset the impact of challenging markets.

Our Healthcare business (Medacs Global Group, MGG) is growing in Ireland and Australasia and we are also winning new business in the competitive Healthcare managed services market in the UK. We continue to work with the NHS to develop and deliver a sustainable temporary workforce for the NHS. However ongoing cost constraints in the public sector, the impact of IR35 and a shortage of candidates are still affecting performance and putting pressure on our conversion of gross margin to EBITDA.

We also continue our strategic IT investment in Ignite, our recruiters' operating system, which is now live in 38 Blue Arrow branches and on site locations having completed a further 18 new implementations in the first half of 2019. We will complete the remaining branches and on site locations by the end of 2019.

On the 8th July Impellam acquired Flexy Corporation Limited, a leading flexible staffing platform. Flexy provides an innovative, data-driven analysis platform to provide insights and consumer-grade digital experiences. The efficiency gained through the utilisation of technology combined with Impellam's deep staffing experience will augment our portfolio and service offering to customers and candidates."

Global Managed Services - UK, Europe, US and Australasia

Gross profit increased by 1.9% to £37.0m (2018: £36.3m) at actual exchange rates but was 0.8% down at constant exchange rates. Adjusted EBITDA (excluding IFRS 16 adjustment) decreased 13.5% (16.4% at constant exchange rates) with conversion of gross profit to adjusted EBITDA of 24.3% compared to 28.7% in the same period last year. Gross profit has increased in the UK although the changing mix of clients continues to impact conversion of gross profit to adjusted EBITDA. In H1, Guidant Global secured 5 significant new customers and Comensura secured 8 new customers. In addition 10 new customer programmes were implemented and went live in Guidant Global (including The Office Groups, Immunomedics, Amway, Johnson Matthey, Crown Castle and Mary Kay).

Global Specialist Staffing - UK, Europe and US

Gross profit increased by 2.6% to £27.4m (2018: £26.7m) at actual exchange rates and 1.2% at constant exchange rates. Adjusted EBITDA (excluding IFRS 16 adjustment) increased 3.8% (1.0% at constant exchange rates) with conversion of gross profit to adjusted EBITDA of 29.6% compared to 29.2% in the same period last year. Lorien were confirmed as a supplier of Interim IT staff services for the Scottish Government. Already Scotland's largest supplier of interim IT workers, their addition to the 4 year Interim IT Staff Services Framework allows them to provide in-demand skills to support key Scottish public sector bodies. Lorien were also appointed to the DPS and G-Cloud 11 frameworks as they continue to expand their public sector practice.

Regional Specialist Staffing - UK and US

Gross profit was flat on 2018 at £47.1m at actual exchange rates (1.6% decrease at constant exchange rates). Adjusted EBITDA (excluding IFRS 16 adjustment) decreased 13.2% (14.9% at constant exchange rates) with conversion of gross profit to adjusted EBITDA of 7.0% compared to 8.1% in the same period last year. The difficult market conditions particularly in retail and automotive as well as the ongoing uncertainty of Brexit are having an impact in this segment, with pressure on gross profit and the brand mix contributing to the fall in conversion to adjusted EBITDA.

Healthcare - UK, Europe and Australasia

Gross profit increased by 3.4% to £24.0m (2018: £23.2m) at actual exchange rates and 4.0% at constant exchange rates. Adjusted EBITDA (excluding IFRS 16 adjustment) decreased 7.7% (2.5% at constant exchange rates) with conversion of gross profit to adjusted EBITDA of 5.0% compared to 5.6% in the same period last year. The European and Australasia businesses are growing year on year however the UK business continues to be impacted by cost constraints in the public sector, IR35 and a shortage of candidates. MGG's strategy of entering the staff bank market in the UK is gaining momentum. Building on a successful performance in the Department of Health and Social Care's Flexible Staff Bank Pilots, MGG has been awarded its second Staff Bank Management Contract, which went live in May.

Cash flow, net debt and net assets

The Group generated £22.4 million of cash from operations in the first twenty-six weeks of the year (2018: £8.7 million). Days Sales Outstanding, being total trade receivables divided by average daily invoiced sales, reduced by 0.6 days from 39.5 days at the end of FY2018 to 38.9 days at the end of H1 2019. Day-to-day control of cash and tight control of working capital continues to be a priority for the Group. Net debt reduced by 5.2% year on year from £79.1m H1 2018 to £75.0m in H1 2019 excluding the impact of IFRS 16. This was up from £71.7m at the end of FY2018 which included the benefits of strong receipts prior to the year end. IFRS 16 increases net debt by £24.9m to £99.9m in H1 2019.

The Group has outstanding letters of credit drawn against its US borrowing facilities amounting to £3.6 million (4 January 2019: £5.1 million).

At 5 July 2019, the Group had net assets of £261.0 million (4 January 2019: £269.4 million).

 

 

Dividend and dividend policy

The Board has not declared an interim dividend. Instead, the Group will undertake a share buyback programme commencing in Q3 2019, whereby it will return cash to shareholders though the purchase of ordinary shares in the Company, up to an aggregate market value of £12 million over a period of 12 months. The Board is of the opinion that, as the buyback programme delivers improvements to underlying EPS, it remains in the best interests of shareholders. The proposed quantum of the buyback, being £12 million, reflects the value that the Board would otherwise have intended to return to shareholders through dividends over the same period.

Trading outlook

We do not anticipate an improvement in external market conditions in H2 but we expect an improvement in conversion of gross profit to adjusted EBITDA due to a reduced cost base driven by our transformation to an integrated business model and the implementation and go-live of known managed services wins.

1. Group Supply is the value of the Spend Under Management supplied by other areas of the Group.

 

Financial results for the twenty-six weeks to 5 July 2019

The table below sets out the results for the Group by segment for the first half of 2019.

 

 

Unaudited

Revenue

Gross profit

Adjusted EBITDA3

£'million

2019

2018

Like-for-like change1

2019

2018

Like-for-like change1

2019

2018

Like-for-like change1

Global Managed Services

372.0

350.3

5.0

37.0

36.3

(0.8)

9.0

10.4

(16.4)

Gross profit %

 

 

 

 

9.9%

10.4%

 

 

 

 

Global Specialist Staffing

336.0

339.1

(1.5)

27.4

26.7

1.2

8.1

7.8

1.0

Gross profit %

 

 

 

 

8.2%

7.9%

 

 

 

 

Regional Specialist Staffing

326.5

330.6

(3.1)

47.1

47.1

(1.6)

3.3

3.8

(14.9)

Gross profit %

 

 

 

 

14.4%

14.2%

 

 

 

 

Healthcare

122.1

120.7

1.8

24.0

23.2

4.0

1.2

1.3

(2.5)

Gross profit %

 

 

 

 

19.7%

19.2%

 

 

 

 

Inter-segment revenues

(21.6)

(33.0)

 

-

-

 

-

-

 

Total

1,135.0

1,107.7

 

135.5

133.3

 

21.6

23.3

 

Corporate costs

 

 

 

 

 

 

(1.5)

(1.2)

 

IFRS 16 adjustment2

 

 

 

 

 

5.0

-

 

Adjusted EBITDA before separately disclosed items and share based payments3

 

 

25.1

22.1

 

Depreciation and amortisation4

 

 

 

 

 

(9.2)

(3.9)

 

Loss on disposal

 

 

 

 

 

-

(0.3)

 

Adjusted operating profit5

 

 

 

 

 

15.9

17.9

 

Amortisation of acquired intangible assets

 

 

 

 

(5.0)

(1.8)

 

Separately disclosed items

 

 

 

 

 

(1.5)

(0.4)

 

Share-based payments

 

 

 

 

 

-

(0.4)

 

Operating profit

 

 

 

 

 

 

9.4

15.3

 

 

 

 

1. % change measured at constant exchange rates.

2. IFRS 16 adjustment is the add back of operating lease charges (see note 2).

3. Adjusted EBITDA is EBITDA before separately disclosed items and share-based payments.

4. Includes IFRS 16 amortisation (see note 2).

5. Before separately disclosed items, share-based payments and amortisation of acquired intangibles.

 

Consolidated income statement

For the twenty-six weeks ended 5 July 2019

 

 

26 weeks

5 July

2019

26 weeks

29 June

2018

 

Notes

£m

£m

 

 

Unaudited

Unaudited (as restated)

Continuing operations

 

 

 

Revenue

2

1,135.0

1,107.7

Cost of sales

 

(999.5)

(974.4)

Gross profit

2

135.5

133.3

Administrative expenses

 

(126.1)

(118.0)

Operating profit

2

9.4

15.3

Adjusted operating profit

 

15.9

17.9

Amortisation of acquired intangible assets

 

(5.0)

(1.8)

Separately disclosed items

5

(1.5)

(0.4)

Share-based payment

 

-

(0.4)

Operating profit

 

9.4

15.3

Finance expense

6

(3.8)

(3.2)

Profit before taxation

 

5.6

12.1

Taxation

7

(1.4)

(1.6)

Profit for the period from continuing operations

4.2

10.5

Profit from discontinued operations, net of tax

0.7

0.1

Profit for the period attributable to owners of the parent Company

4.9

10.6

 

 

 

 

 

 

Earnings per share for equity holders of the parent Company

 

 

 

Basic

8

9.9 p

21.0p

Diluted

8

9.9 p

20.7p

 

 

 

 

 

 

Consolidated statement of comprehensive income

For the twenty-six weeks ended 5 July 2019

 

26 weeks

5 July

2019

26 weeks

29 June

2018

 

£m

£m

 

Unaudited

Unaudited

Profit for the period

4.9

10.6

Other comprehensive income:

 

 

Currency translation differences (net of tax)

2.2

1.2

Total comprehensive income for the period, net of tax, attributable to owners of the parent Company

7.1

11.8

 

 

 

 

 

Consolidated balance sheet

As at 5 July 2019

 

 

5 July 2019

4 January 2019

 

 

 

£m

£m

 

 

 

Unaudited

Audited

 

Non-current assets

 

 

 

 

Property, plant and equipment

 

31.2

6.7

 

Goodwill

 

152.8

156.2

 

Other intangible assets

 

127.4

131.1

 

Financial assets

 

1.5

1.4

 

Deferred tax assets

 

15.1

15.3

 

 

 

328.0

310.7

 

Current assets

 

 

 

 

Trade and other receivables

 

604.2

569.1

 

Cash and cash equivalents

 

89.2

77.2

 

 

 

693.4

646.3

 

Total assets

 

1,021.4

957.0

 

Current liabilities

 

 

 

 

Short-term borrowings

 

34.3

25.1

 

Trade and other payables

 

540.1

508.3

 

Taxation payable

 

1.9

1.7

 

Provisions

 

0.9

0.9

 

 

 

577.2

536.0

 

Net current assets

 

116.2

110.3

 

Non-current liabilities

 

 

 

 

Long-term borrowings

 

154.8

123.8

 

Other payables

 

2.1

1.6

 

Provisions

 

3.3

3.4

 

Deferred tax liabilities

 

23.0

22.8

 

 

 

183.2

151.6

 

Total liabilities

 

760.4

687.6

 

Net assets

 

261.0

269.4

 

Equity

 

 

 

Issued share capital

 

0.5

0.5

Share premium account

 

30.1

30.1

 

 

30.6

30.6

Other reserves

 

126.8

124.6

Retained earnings

 

103.6

114.2

Total equity attributable to owners of the parent Company

261.0

269.4

Non-controlling interest

 

-

-

Total equity

 

261.0

269.4

 

 

Consolidated statement of changes in equity

For the twenty-six weeks ended 5 July 2019

 

Total share capital and share premium

Other reserves

Retained earnings

Total equity attributable to equity owners of the parent

Non-controlling interest

Total equity

Unaudited

£ m

£ m

£ m

£ m

£ m

£ m

5 January 2019

30.6

124.6

114.2

269.4

-

269.4

Profit for the period

-

-

4.9

4.9

-

4.9

Other comprehensive income

-

2.2

-

2.2

-

2.2

Total comprehensive income in the period

-

2.2

4.9

7.1

-

7.1

Transactions with owners, recorded directly in equity

 

 

 

 

 

 

Purchase of Treasury shares

-

-

(5.7)

(5.7)

-

(5.7)

De-merger charge

-

-

(8.1)

(8.1)

-

(8.1)

Dividend

-

-

(1.7)

(1.7)

-

(1.7)

5 July 2019

30.6

126.8

103.6

261.0

-

261.0

 

 

 

 

 

 

 

 

 

 

 

Consolidated cash flow statement

For the twenty-six weeks ended 5 July 2019

 

26 weeks

5 July

2019

26 weeks

29 June

2018

 

£m

£m

 

Unaudited

Unaudited

(as restated)

Cash flows from operating activities

 

 

Profit before taxation

5.6

12.1

Adjustments for:

 

 

Net interest charge

3.8

3.2

Depreciation and amortisation

14.2

5.7

Loss on disposal

-

0.3

Discontinued operations

(0.7)

0.1

Share-based payment

-

0.4

 

22.9

21.8

(Increase) / Decrease in trade and other receivables

(39.5)

67.1

Increase / (Decrease) in trade and other payables

39.1

(80.1)

Decrease in provisions

(0.1)

(0.1)

Cash generated by operations

22.4

8.7

Taxation paid

(1.6)

(3.1)

Net cash generated by operating activities

20.8

5.6

Cash flows from investing activities

 

 

Payment of deferred consideration

(0.8)

(0.7)

Purchase of property, plant and equipment

(5.3)

(2.1)

Purchase of intangible assets

(4.0)

(3.0)

Cash outflow on discontinued operations

(2.5)

-

Net movement in other financial assets

(0.1)

-

Net cash utilised on investing activities

(12.7)

(5.8)

Cash flows from financing activities

 

 

Decrease / (Increase) in short-term borrowings

15.5

(14.0)

Purchase of treasury shares

(5.7)

(0.5)

Finance expense paid

(3.8)

(3.1)

Repayment of lease liabilities (2018: Capital element of net finance lease payments)

(4.3)

0.6

Inflow from new leases

3.6

-

Net cash inflow / (outflow) from financing activities

5.3

(17.0)

Net increase / (decrease) in cash and equivalents

13.4

(17.2)

Opening cash and cash equivalents

77.2

100.3

Foreign exchange (loss) / gain on cash and cash equivalents

(1.4)

0.5

Closing cash and cash equivalents

89.2

83.6

 

 

 

 

 

Notes to the interim financial statements

1 Basis of preparation

I. Statement of compliance

The interim financial statements presented in this financial report have been prepared in accordance with International Financial Reporting Standards (IFRS) and the IFRS Interpretations Committee (IFRIC) interpretations as endorsed by the European Union that are expected to be applicable to the consolidated financial statements for the period ending 3 January 2020. As permitted, this interim report has been prepared in accordance with the AIM Rules for Companies and does not seek to comply with IAS 34 "Interim Financial Reporting".

II. Statutory information

The financial information for the 26 weeks to 5 July 2019 does not constitute the statutory accounts of the Group for the relevant period within the meaning of section 434 of the Companies Act 2006.

The published annual report and accounts of Impellam Group plc for the period ended 5 January 2019 were reported on by the auditors without qualification, did not contain an emphasis of matter paragraph, did not contain any statement under section 498 of the Companies Act 2006, and have been delivered to the Registrar of Companies.

III. Accounting policies, new IFRS and interpretations

The accounting policies used in this report are with those applied at 5 January 2019, but have also adopted the following new IFRS.

a) IFRS 9 - Financial Instruments. As disclosed in the last annual report the Group has had no significant changes since the adoption of this standard.

b) IFRS 15 - Revenue from Contracts with Customers. The Group has adjusted the level of revenue recognised on the agency-principal basis. This will purely lead to amendments to revenue and cost of sales with no change in gross profit (see note 4).

c) IFRS 16 - Leases. The Group has reviewed its portfolio of leases as at 5 January 2019 and decided to account for IFRS 16 on the modified retrospective approach using a single discount rate for portfolio leases with similar characteristics. Advantage has been taken of the exemption provided for low value leases. The Group is using the methodology to set the right-of-use asset equal to the lease liability upon adoption of IRFS 16.

No other new and/or revised IFRS and IFRIC publications that come into force in the period have any material impact on the accounting policies, financial position or performance of the Group.

 

 

 

2 Segmental information

Twenty-six weeks ended 5 July 2019 - unaudited

 

 

 

Revenue

Gross profit

Segment

Adjusted EBITDA

 

 

 

£ m

£ m

£ m

 

Global Managed Services

 

372.0

37.0

9.0

 

Global Specialist Staffing

 

336.0

27.4

8.1

 

Regional Specialist Staffing

 

326.5

47.1

3.3

 

Healthcare

 

122.1

24.0

1.2

 

Inter-segment revenues

 

(21.6)

-

-

 

Operating segments

 

1,135.0

135.5

21.6

 

Twenty-six weeks ended 29 June 2018 - unaudited (as restated)

 

 

 

Revenue

Gross profit

Segment

Adjusted EBITDA

 

 

 

£ m

£ m

£ m

 

Global Managed Services

 

350.3

36.3

10.4

 

Global Specialist Staffing

 

339.1

26.7

7.8

 

Regional Specialist Staffing

 

330.6

47.1

3.8

 

Healthcare

 

120.7

23.2

1.3

 

Inter-segment revenues

 

(33.0)

-

-

 

Operating segments

 

1,107.7

133.3

23.3

 

 

 Unaudited

 

 

26 weeks5 July2019

 £ m

26 weeks29 June2018

 £ m

 

Segment adjusted EBITDA

 

21.6

23.3

 

Corporate costs

 

(1.5)

(1.2)

 

IFRS 16 adjustment

 

5.0

-

 

Adjusted EBITDA before Separately Disclosed items and share-based payment

 

25.1

22.1

 

Amortisation and depreciation

 

(9.2)

(3.9)

 

Loss on disposal

 

-

(0.3)

 

Adjusted operating profit

 

15.9

17.9

 

Amortisation of acquired intangibles

 

(5.0)

(1.8)

 

Separately disclosed items

 

(1.5)

(0.4)

 

Share-based payment

 

-

(0.4)

 

Operating profit

 

9.4

15.3

 

Finance expense

 

(3.8)

(3.2)

 

Taxation charge

 

(1.4)

(1.6)

 

Profit for the period from continuing operations

 

4.2

10.5

 

 

 

 

 

 

The above table reconciles the adjusted Earnings Before Interest, Tax, Depreciation and Amortisation ('EBITDA'), which also excludes separately disclosed items and share-based payments to the standard profit measure under International Financial Reporting Standards (Operating Profit). This is the Alternative Profit Measure used when discussing the performance of the Group. The Directors believe that adjusted EBITDA is the most appropriate approach for ascertaining the underlying trading performance and trends as it reflects the measures used internally by senior management for all discussions of performance, including Directors' remuneration, and also reflects the starting profit measure used when calculating the Group's banking covenants. All discussions within the Group on segmental and individual brand performance refer to adjusted EBITDA. Corporate costs represent costs associated with being a listed company with a wide portfolio of brands and therefore are not allocated to the segments.

Following the adoption of IFRS 16 in 2019 the Group is moving to adjusted operating profit as its Alternative Profit Measure, to include depreciation and amortisation of assets but excluding amortisation of acquired intangibles, and this is included in the above table for reference. As this transition has not been finished, the segmental analysis has been completed with operating lease payments included within the segment numbers so that the year-on-year performance is comparable. An adjustment is therefore made to remove these costs to get to Adjusted EBITDA.

Adjusted EBITDA is not defined by IFRS and therefore may not be directly comparable with other companies' alternative profit measures. It is not intended to be a substitute, or superior to, IFRS measurements of profit.

Separately disclosed items are costs or income that have been recognised in the income statement which the Directors believe, due to their nature or size, should be disclosed separately to give a more comparable view of the year-on-year underlying financial performance (note 5).

Share-based payments are shown separately due to their size in order to give a more comparable view of the year on year underlying financial performance.

3 Discontinued operations

In March 2019 the Group de-merged Carlisle Support Services Group Ltd and its subsidiaries ("CSS").

The CSS segment was not previously classified as held-for-sale or as a discontinued operation. The comparative consolidated statement of profit or loss and consolidated statement of comprehensive income has been re-presented to show the discontinued operation separately from continuing operations.

Subsequent to the disposal, the Group has continued to trade with the discontinued operation. Intra-group transactions have been fully eliminated in consolidated financial results and management has elected not to attribute the elimination of transactions between the continuing operations and the discontinued operation before the disposal as the level of this is small in comparison to the total trade of both the continuing and discontinued trade.

 

 

 

Results from discontinued operations

 

 

26 weeks

5 July

2019

26 weeks

29 June

2018

 

 

£m

£m

 

 

Unaudited

Unaudited

Revenue

 

9.6

25.8

Cost of sales

 

(8.7)

(23.6)

Gross profit

 

0.9

2.2

Administrative expenses

 

(0.2)

(2.1)

Profit from operating activities

 

0.7

0.1

Taxation

 

-

-

Profit from discontinued operations

0.7

0.1

 

Cash flows relating to discontinued operations

26 weeks

5 July

2019

26 weeks

29 June

2018

 

£m

£m

 

Unaudited

Unaudited

Net cash generated by operating activities

0.5

(0.3)

Net cash (outflow) from financing activities

(0.1)

-

Net cash flows for discontinued operations

0.4

(0.3)

 

 

 

Effect of disposal on the financial position of the Group

 

 

5 July

2019

 

 

£m

 

 

Unaudited

Property, plant and equipment

 

0.5

Goodwill

 

4.8

Deferred tax assets

 

0.3

Trade and other receivables

 

9.9

Cash and cash equivalents

 

2.5

Trade and other payables

 

(8.7)

Lease liabilities

 

(0.3)

Net assets and liabilities

 

9.0

 

 

 

 

4 Comparative restatement

As well as the re-statement for discontinued operations in note 3, and following the adoption of IFRS 15 - Revenue from Contracts with Customers, the Group has completed a review of the accounting for revenue under the Agency/Principal basis which has led to an increase in revenue for the Group for the 26 weeks to 29 June 2018 of £23.9m with a corresponding decrease in cost of sales.

 

 

5 Separately disclosed items - unaudited

 

26 weeks5 July

2019

26 weeks29 June

2018

 

£ m

£ m

Acquisition costs (1)

(0.4)

0.4

Group de-merger (2)

0.8

-

Legal costs (3)

1.1

-

 

1.5

0.4

 

 

 

(1) Acquisition costs relate to contingent consideration in respect of Global Medics in 2019 and 2018. 2018 costs also include a provision for bonuses following synergies arising from the acquisition of Bartech in 2015. These costs are one-off in nature and have been disclosed in order not to distort the underlying trading performance of the business.

(2) The Group de-merged Carlisle Support Services Group in 2019, incurring costs of £0.8m. These costs are one-off in nature and have been disclosed in order not to distort the underlying trading performance of the business.

(3) In 2019 the Group negotiated an amend and extend to its Revolving credit facilities ("RCF") arrangement before the 2020 expiry date, the outstanding fees for the original RCF have been taken as a cost in 2019. In addition the Group had an ongoing litigation matter for which a provision was made in 2018, in 2019 a further £0.1m of legal costs was incurred. These are disclosed separately due to their one-off nature and significance.

6 Finance expense - unaudited

 

Finance expense

 

26 weeks5 July2019£ m

26 weeks29 June2018£ m

 

 

Revolving credit facilities

 

3.2

3.1

 

 

Interest on lease liabilities

 

0.6

-

 

 

Other interest expense

 

-

0.1

 

 

Income statement

 

3.8

3.2

 

 

 

 

 

 

 

7 Taxation - unaudited

Income tax expense is recognised based on management's best estimate of the effective annual income tax rate expected for the full financial year. Included in the current period total is a charge of £0.7m in relation to corrections to the provision of the prior period.

8 Earnings per share - unaudited

Basic earnings per share amounts are calculated by dividing the profit for the period attributable to the owners of the Company by the weighted average number of Ordinary shares outstanding during the period.

Diluted earnings per share amounts are calculated on the same basis but after adjusting the denominator for the effects of dilutive options. The only potentially dilutive shares arise from the share options issued by the Group under its share-based compensation plans. There were no options outstanding at 5 July 2019 (29 June 2018: 850,000).

Excluding the 19,841 shares owned by The Corporate Services Group Ltd Employee Share Trust, the weighted average number of shares in 2019 is 49,160,900 (2018: 50,270,957) and the fully diluted average number of shares is 49,180,741 (2018: 51,140,798).

 

 

26 weeks5 July2019

26 weeks29 June2018

 

£m

£m

(as restated)

Continuing profit for the period

4.2

10.5

Discontinued profit for the period

0.7

0.1

Total profit for the period

4.9

10.6

Separately disclosed items (net of tax)

1.3

0.8

Acquired intangibles amortisation (net of tax)

4.0

1.5

Total adjusted profit

10.2

12.9

Continuing adjusted profit

9.5

12.8

Discontinued adjusted profit

0.7

0.1

 

 

 

Weighted average number of shares

49,160,900

50,270,957

 

 

 

 

26 weeks5 July2019

26 weeks29 June2018

Basic EPS

Pence

Pence

(as restated)

Continuing unadjusted basic earnings per share

8.5

20.9

Discontinued unadjusted basic earnings per share

1.4

0.1

Total unadjusted basic earnings per share

9.9

21.0

Separately disclosed items (net of tax)

2.6

1.5

Acquired intangible asset amortisation (net of tax)

8.1

2.9

Total adjusted basic earnings per share

20.6

25.4

Continuing adjusted basic earnings per share

19.2

25.3

Discontinued unadjusted basic earnings per share

1.4

0.1

 

 

 

Fully diluted weighted average number of shares

49,180,741

51,140,798

 

 

 

 

26 weeks5 July2019

26 weeks29 June2018

(as restated)

Diluted EPS

Pence

Pence

Continuing unadjusted diluted earnings per share

8.5

20.6

Discontinued unadjusted diluted earnings per share

1.4

0.1

Total unadjusted diluted earnings per share

9.9

20.7

Separately disclosed items (net of tax)

2.6

1.5

Acquired intangible asset amortisation (net of tax)

8.1

2.8

Total adjusted diluted earnings per share

20.6

25.0

Continuing adjusted diluted earnings per share

19.2

24.9

Discontinued unadjusted diluted earnings per share

1.4

0.1

 

 

9 Additional cash flow information - unaudited

Unaudited

5 January 2019

Cash flow

Interest paid

Interest expense

Change in short term borrowings

Foreign exchange

5 July 2019

 

£ m

£ m

£ m

£ m

£ m

£ m

£ m

Cash and short-term deposits

77.2

(2.1)

-

-

15.5

(1.4)

89.2

Revolving credit

(148.5)

-

(3.2)

3.2

(15.5)

0.1

(163.9)

Hire purchase

(0.4)

0.1

-

-

-

-

(0.3)

Lease liabilities

-

4.9

(0.6)

0.6

(29.7)

(0.1)

(24.9)

Net debt

(71.7)

2.9

(3.8)

3.8

(29.7)

(1.4)

(99.9)

 

 

 

 

 

 

 

 

 

10 Leases

Property, plant and equipment comprise owned and leased assets, including right-of-use assets which have been created under IFRS 16 - Leases. Information about these assets and the related lease liabilities are presented below.

Total property, plant and equipment

5 July

2019

5 January 2019

 

£ m

£ m

Property, plant and equipment (owned)

6.6

6.7

Right of use assets

24.6

-

 

31.2

6.7

 

Right of use assets

 

Property

Vehicles

Total

 

 

£ m

£ m

£ m

Balance at 5 January 2019

 

-

-

-

Additions in the period

 

28.1

1.4

29.5

Depreciation charge in the period

 

(4.2)

(0.3)

(4.5)

Disposals (net)

 

-

(0.3)

(0.3)

Impairment

 

(0.1)

-

(0.1)

Foreign exchange (net)

 

0.1

-

0.1

Balance at 5 July 2019

 

23.9

0.8

24.7

 

 

 

 

 

Lease liability maturity analysis

Discounted contractual cash flows

Property

Vehicles

Total

 

£ m

£ m

£ m

Less than one year

8.9

0.5

9.4

More than one year but less than five years

12.4

0.3

12.7

More than five years

2.8

-

2.8

 

24.1

0.8

24.9

 

 

Enquiries: For further information please contact:

Impellam Group plc

Julia Robertson, Group Chief Executive

Tel: 01582 692658

 

Cenkos Securities plc (NOMAD and Corporate Broker to Impellam)

Nicholas Wells

Callum Davidson

Tel: 020 7397 8900

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014

 

Note to Editors:

 

Impellam is the second largest1 staffing company in the UK and sixth largest2 Managed Services provider worldwide. Our vision is to be the world's most trusted staffing company - trusted by our people, our customers and our investors in equal measure.

 

We provide Managed Services and Specialist Staffing solutions across the UK, Europe, US, the Middle East and Australasia. We have over 3,200 Impellam people throughout our network of 17 market-leading brands across 165 worldwide locations.

 

Ultimately, Impellam Group's mission is to provide fulfilment and a sense of purpose to our people and to help customers build better businesses in a changing world.

 

For more information about Impellam Group please visit: www.impellam.com

 

 

 

1 By revenue (2017 published numbers)

2 By SUM (confirmed by Staffing Industry Analysts). Spend Under Management (SUM) is the total amount of client expenditure which our Managed Services brands manage on behalf of their clients. This equates to revenue earned where Impellam acts as principal plus gross billings to customers where Impellam acts as agent (2017 published numbers). Management use this measure as it reflects the total value of the client spend to the Group and not just the revenue generated

 

 

-END-

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IR LFFSLDLIAFIA
Date   Source Headline
22nd Mar 20247:00 amRNSCancellation - IMPELLAM GROUP PLC
21st Mar 202410:36 amRNSScheme of Arrangement becomes Effective
21st Mar 20247:30 amRNSSuspension - Impellam Group plc
19th Mar 20243:59 pmRNSCourt Sanction of the Scheme of Arrangement
18th Mar 20246:00 pmRNSImpellam Group
15th Mar 202411:46 amRNSForm 8.3 - Impellam Group PLC
15th Mar 202410:58 amRNSForm 8.5 (EPT/RI)
15th Mar 20248:36 amRNSTransaction in Own Shares & Rule 2.9 Announcement
15th Mar 20247:00 amRNSBidco Share Capital Adjustments
14th Mar 20243:30 pmRNSForm 8.3 - IPEL LN
14th Mar 202412:10 pmRNSForm 8.3 - Impellam Group PLC
14th Mar 20248:30 amRNSForm 8.5 (EPT/NON-RI) Impellam Group Plc
12th Mar 20247:00 amRNSUpdate on Declaration of Dividend in Specie
11th Mar 20241:48 pmRNSForm 8.3 - Impellam Groupl plc
4th Mar 20247:00 amRNSUpdate on Offer Conditions and Timetable
27th Feb 20248:17 amRNSForm 8.5 (EPT/RI)
27th Feb 20247:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
26th Feb 20243:27 pmRNSForm 8.3 - Impellam Group Plc
23rd Feb 20242:44 pmRNSForm 8.5 (EPT/RI)
23rd Feb 20247:22 amRNSTransaction in Own Shares & Rule 2.9 Announcement
22nd Feb 20249:10 amRNSForm 8.5 (EPT/RI)
21st Feb 20243:46 pmRNSUpdate on Offer Conditions
21st Feb 202410:09 amRNSForm 8.5 (EPT/RI) - Impellam Group plc
15th Feb 202410:12 amRNSForm 8.3 - Impellam Group Plc
14th Feb 20241:06 pmRNSForm 8.3 - Impellam Group Plc
14th Feb 20247:41 amRNSForm 8.5 (EPT/NON-RI) Impellam Group Plc
13th Feb 202411:21 amRNSForm 8.3 - Impellam Group PLC
8th Feb 20247:00 amRNSDeclaration of Dividend in Specie
7th Feb 20242:21 pmRNSForm 8.3 - Impellam Group PLC
1st Feb 202412:12 pmRNSForm 8.3 - Impellam Group PLC
1st Feb 202411:20 amRNSForm 8.5 (EPT/NON-RI) Impellam Group Plc
25th Jan 202410:29 amRNSForm 8.5 (EPT/RI)
25th Jan 20247:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
24th Jan 20247:00 amRNSSpecial Cash Dividend Declaration
23rd Jan 202411:56 amRNSForm 8.5 (EPT/RI)
23rd Jan 20248:20 amRNSForm 8.5 (EPT/NON-RI) Impellam Group Plc
23rd Jan 20247:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
22nd Jan 20249:27 amRNSForm 8.5 (EPT/RI)
22nd Jan 20247:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
19th Jan 20249:58 amRNSForm 8.5 (EPT/RI)
19th Jan 20247:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
18th Jan 20243:30 pmRNSForm 8.3 - IPEL LN
18th Jan 202411:08 amRNSForm 8.5 (EPT/RI)
18th Jan 20249:20 amRNSForm 8.5 (EPT/NON-RI) Impellam Group Plc
18th Jan 20247:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
17th Jan 20245:01 pmRNSResults of Court Meeting and General Meeting
16th Jan 20243:30 pmRNSForm 8.3 - IPEL LN
12th Jan 20243:30 pmRNSForm 8.3 - IPEL LN
11th Jan 20243:30 pmRNSForm 8.3 - IPEL LN
11th Jan 20242:05 pmRNSForm 8.3 - Impellam Group PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.